3-fluoro-4-((6-methylpyridin-3-yl)oxy)benzaldehyde | 1369256-80-3

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 3-fluoro-4-((6-methylpyridin-3-yl)oxy)benzaldehyde
• 英文别名: 3-Fluoro-4-(6-methylpyridin-3-yl)oxybenzaldehyde
• CAS: 1369256-80-3
• 化学式: C₁₃H₁₀FNO₂
• 分子量: 231.226
• InChiKey: OCDIXLIEHDFWPU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  17
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  39.2
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  3-fluoro-4-((6-methylpyridin-3-yl)oxy)benzaldehyde 在 盐酸羟胺 、 盐酸 、 锌 作用下， 以 乙醇 为溶剂， 反应 1.25h， 生成 [3-Fluoro-4-(6-methylpyridin-3-yl)oxyphenyl]methanamine
  参考文献：
  名称：

  Structure–Activity Relationship Studies of Tolfenpyrad Reveal Subnanomolar Inhibitors ofHaemonchus contortusDevelopment

  摘要：

  Recently, we have discovered that the registered pesticide, tolfenpyrad, unexpectedly and potently inhibits the development of the L4 larval stage of the parasitic nematode Haemonchus contortus with an IC50 value of 0.03 mu M while displaying good selectivity, with an IC50 of 37.9 mu M for cytotoxicity. As a promising molecular template for medicinal chemistry optimization, we undertook anthelmintic structure-activity relationships for this chemical. Modifications of the left-hand side (LHS), right-hand side (RHS), and middle section of the scaffold were explored to produce a set of 57 analogues. Analogues 25, 29, and 33 were shown to be the most potent compounds of the series, with IC50 values at a subnanomolar level of potency against the chemotherapeutically relevant fourth larval (L4) stage of H. contortus. Selected compounds from the series also showed promising activity against a panel of other different parasitic nematodes, such as hookworms and whipworms.

  DOI：

  10.1021/acs.jmedchem.8b01789
• 作为产物：
  描述：

  3-羟基-6-甲基吡啶 、 3,4-二氟苯甲醛 在 caesium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 2.0h， 生成 3-fluoro-4-((6-methylpyridin-3-yl)oxy)benzaldehyde
  参考文献：
  名称：

  Structure–Activity Relationship Studies of Tolfenpyrad Reveal Subnanomolar Inhibitors ofHaemonchus contortusDevelopment

  摘要：

  Recently, we have discovered that the registered pesticide, tolfenpyrad, unexpectedly and potently inhibits the development of the L4 larval stage of the parasitic nematode Haemonchus contortus with an IC50 value of 0.03 mu M while displaying good selectivity, with an IC50 of 37.9 mu M for cytotoxicity. As a promising molecular template for medicinal chemistry optimization, we undertook anthelmintic structure-activity relationships for this chemical. Modifications of the left-hand side (LHS), right-hand side (RHS), and middle section of the scaffold were explored to produce a set of 57 analogues. Analogues 25, 29, and 33 were shown to be the most potent compounds of the series, with IC50 values at a subnanomolar level of potency against the chemotherapeutically relevant fourth larval (L4) stage of H. contortus. Selected compounds from the series also showed promising activity against a panel of other different parasitic nematodes, such as hookworms and whipworms.

  DOI：

  10.1021/acs.jmedchem.8b01789

文献信息

• [EN] TRICYCLIC COMPOUNDS, PREPARATION METHODS, AND THEIR USES<br/>[FR] COMPOSÉS TRICYCLIQUES, LEURS PROCÉDÉS DE PRÉPARATION ET LEURS UTILISATIONS
  申请人：GLAXO GROUP LTD

  公开号：WO2012037782A1

  公开（公告）日：2012-03-29

  The present invention relates to novel compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease, and/or diabetic macular edema.

  本发明涉及抑制Lp-PLA2活性的新化合物，以及它们的制备方法、含有它们的组合物，以及它们在治疗与Lp-PLA2活性相关的疾病中的应用，例如动脉粥样硬化、阿尔茨海默病和/或糖尿病黄斑水肿。
• TRICYCLIC COMPOUNDS, PREPARATION METHODS, AND THEIR USES
  申请人：Glaxo Group Limited

  公开号：EP2619203A1

  公开（公告）日：2013-07-31
• US8871928B2
  申请人：——

  公开号：US8871928B2

  公开（公告）日：2014-10-28
• Structure–Activity Relationship Studies of Tolfenpyrad Reveal Subnanomolar Inhibitors of<i>Haemonchus contortus</i>Development
  作者：Thuy G. Le、Abhijit Kundu、Atanu Ghoshal、Nghi H. Nguyen、Sarah Preston、Yaqing Jiao、Banfeng Ruan、Lian Xue、Fei Huang、Jennifer Keiser、Andreas Hofmann、Bill C. H. Chang、Jose Garcia-Bustos、Timothy N. C. Wells、Michael J. Palmer、Abdul Jabbar、Robin B. Gasser、Jonathan B. Baell

  DOI：10.1021/acs.jmedchem.8b01789

  日期：2019.1.24

  Recently, we have discovered that the registered pesticide, tolfenpyrad, unexpectedly and potently inhibits the development of the L4 larval stage of the parasitic nematode Haemonchus contortus with an IC50 value of 0.03 mu M while displaying good selectivity, with an IC50 of 37.9 mu M for cytotoxicity. As a promising molecular template for medicinal chemistry optimization, we undertook anthelmintic structure-activity relationships for this chemical. Modifications of the left-hand side (LHS), right-hand side (RHS), and middle section of the scaffold were explored to produce a set of 57 analogues. Analogues 25, 29, and 33 were shown to be the most potent compounds of the series, with IC50 values at a subnanomolar level of potency against the chemotherapeutically relevant fourth larval (L4) stage of H. contortus. Selected compounds from the series also showed promising activity against a panel of other different parasitic nematodes, such as hookworms and whipworms.